抗NMDAR脑炎长期认知结局的前瞻性纵向研究
该前瞻性纵向研究对43例抗NMDAR脑炎患者在发病后中位2.3年及4.9年进行标准化综合神经心理评估,并与30名健康对照比较。所有患者2.3年时均存在持续认知缺陷,超过80%为中重度损害;4.9年时认知功能显著改善,但三分之二患者仍残留中重度缺陷,尽管功能神经学结局良好(中位mRS=1)。延迟治疗、疾病严重度更高及急性期更长是认知结局不良的预测因素。
要点
- 抗NMDAR脑炎患者发病后2.3年全部存在持续认知缺陷,超80%为中重度。
- 4.9年时认知显著改善,但三分之二患者仍残留中重度缺陷,即使功能结局良好。
- 延迟治疗、疾病严重度更高和急性期更长预测认知结局不良。
核心结论
- 认知缺陷是抗NMDAR脑炎长期疾病负担的主要来源,且持续至功能神经学恢复之后。
- 急性期后数年内认知功能仍可能改善,应持续支持认知康复。
- 未来临床研究应将认知评估纳入结局指标。
研究设计与样本
- 前瞻性纵向研究,纳入43例抗NMDAR脑炎患者,在发病后中位2.3年及4.9年进行标准化综合神经心理评估。
- 认知评估覆盖执行功能、工作记忆、言语/视觉情景记忆、注意力、主观抱怨及抑郁焦虑水平。
- 患者认知表现与30名年龄、性别及教育程度匹配的健康参与者比较。
主要发现
- 所有患者发病后2.3年存在持续认知缺陷,超过80%为中度或重度损害。
- 核心缺陷包括记忆和执行功能。
- 4.9年后认知功能显著改善,但三分之二患者仍存在中重度缺陷,尽管功能神经学结局良好(中位改良Rankin量表=1)。
- 延迟治疗、疾病严重度更高及急性期更长是认知结局不良的预测因素。
- 恢复过程呈时间依赖性,急性期后早期获益更大,但发病后数年仍可能改善。
临床怎么用
- 对功能神经学恢复良好的抗NMDAR脑炎患者仍需评估并关注长期认知缺陷。
- 尽早治疗、降低疾病严重度及缩短急性期可能有助于改善认知结局。
- 急性期后数年内应持续提供认知康复支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cognitive dysfunction is a core symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits, and the potential for recovery are missing. Here, we performed a prospective longitudinal study to assess cognitive long-term outcome and identify clinical predictors. METHODS: Standardized comprehensive neuropsychological assessments were performed in 43 patients with NMDAR encephalitis 2.3 years and 4.9 years (median) after disease onset. Cognitive assessments covered executive function, working memory, verbal/visual episodic memory, attention, subjective complaints, and depression and anxiety levels. Cognitive performance of patients was compared to that of 30 healthy participants matched for age, sex, and education. RESULTS: All patients had persistent cognitive deficits 2.3 years after onset, with moderate or severe impairment in >80% of patients. Core deficits included memory and executive function. After 4.9 years, significant improvement of cognitive function was observed, but moderate to severe deficits persisted in two thirds of patients, despite favorable functional neurological outcomes (median modified Rankin Scale = 1). Delayed treatment, higher disease severity, and longer duration of the acute phase were predictors for impaired cognitive outcome. The recovery process was time dependent, with greater gains earlier after the acute phase, although improvements were possible for several years after disease onset. INTERPRETATION: Cognitive deficits are the main contributor to long-term morbidity in NMDAR encephalitis and persist beyond functional neurological recovery. Nonetheless, cognitive improvement is possible for several years after the acute phase and should be supported by continued cognitive rehabilitation. Cognition should be included as an outcome measure in future clinical studies. ANN NEUROL 2021;90:949-961.
引用
- Heine J, Kopp UA, Klag J, et al. Long-Term Cognitive Outcome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Ann Neurol. 2021. PMID: 34595771. doi:10.1002/ana.26241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。